AVRA
  • Home
  • About
    • Who we are
    • What we do
    • The rationale for AVRA
    • A robust vaccine pipeline
    • The global and national context
    • Expected benefits
    • Governance and management
  • Key Activities
    • Antigen surveillance
    • Vaccine platform technologies
    • Adjuvant development
    • Antigen discovery
    • Animal models
    • Vaccine immunity
    • Vaccine manufacturing partners
    • Clinical trials
    • Education and training
  • People
  • Partners
  • News and Events
  • Contact
Menu

News and events

SARS-CoV-2 antibody signature

SARS-CoV-2 antibody signature

Mar 1, 2021

read more
Infection and immunity masterclass series

Infection and immunity masterclass series

Aug 28, 2020

read more
UQ vaccine scientists report positive results from pre-clinical testing

UQ vaccine scientists report positive results from pre-clinical testing

Aug 26, 2020

read more
The history of vaccines, from smallpox to SARS and beyond

The history of vaccines, from smallpox to SARS and beyond

Aug 26, 2020

read more
What to expect from a COVID-19 vaccine

What to expect from a COVID-19 vaccine

Aug 20, 2020

read more
Sydney researchers test tuberculosis vaccine combination for COVID-19

Sydney researchers test tuberculosis vaccine combination for COVID-19

Aug 3, 2020

read more
The everyday Australians taking part in a human trial of a coronavirus vaccine

The everyday Australians taking part in a human trial of a coronavirus vaccine

Jul 6, 2020

read more
$17m shot in the arm for UQ’s COVID-19 vaccine research

$17m shot in the arm for UQ’s COVID-19 vaccine research

Mar 22, 2020

read more
Next Entries »

Recent news

  • First antigen test pilot in low prevalence COVID-19 settings signals challenges for rollout
  • SARS-CoV-2 antibody signature
  • Mapping an effective immune response to COVID-19
  • COVID variants and what they mean for the pandemic
  • New method to assist fast-tracking of vaccines for pre-clinical tests

The people behind AVRA

A team of professionals across a wide range of disciplines has been assembled to launch AVRA, across 3 of Australia’s leading research Universities.

read more

ENQUIRIES

P 07 3346 1623  |  M 0499 880 791

The University of Queensland Logo The University of Sydney Logo The University of Melbourne Logo

© 2020 Australian Vaccine Response Alliance (AVRA)